Steven Cohen’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Steven Cohen's REGN Position: Q2 2026 in Review
Steven Cohen sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 2,175 shares — an estimated $1.48M sold.
Steven Cohen first reported a position in REGN in Q2 2014 and held it in 18 quarters. The position peaked at $203M in Q4 2025. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Steven Cohen reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Steven Cohen sold 2,175 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.48M.
- Steven Cohen first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 18 quarters.
- Steven Cohen's Regeneron Pharmaceuticals position peaked at $203M in Q4 2025.
- 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.